The FOXM1-PLK1 axis is commonly upregulated in oesophageal adenocarcinoma

British Journal of Cancer

Volumn 107, Issue 10, 2012, Pages 1766-1775

  Dibb, M ^a,b   Han, N ^a   Choudhury, J ^b   Hayes, S ^b,c   Valentine, H ^a   West, C ^a   Ang, Y S ^b   Sharrocks, A D ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c SALFORD ROYAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

FOXM1; G2 M cell cycle phase; Oesophageal adenocarcinoma; PLK1

Indexed keywords

POLO LIKE KINASE 1; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXM1; UNCLASSIFIED DRUG;

ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; ESOPHAGEAL ADENOCARCINOMA; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; HUMAN TISSUE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TREATMENT OUTCOME; UPREGULATION;

ADENOCARCINOMA; CELL CYCLE PROTEINS; CELL LINE, TUMOR; COHORT STUDIES; ESOPHAGEAL NEOPLASMS; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; PROGNOSIS; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; UP-REGULATION;

EID: 84869083267     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2012.424     Document Type: Article

References (24)

1. Adams R, Morgan M, Mukherjee S, Brewster A, Maughan T, Morrey D, Havard T, Lewis W, Clark G, Roberts S, Vachtsevanos L, Leong J, Hardwick R, Carey D, Crosby T (2007) A prospective comparison of multidisciplinary treatment of oesophageal cancer with curative intent in a UK cancer network. Eur J Surg Oncol 33: 307-313. (Pubitemid 46488667)
2. Coupland VH, Allum W, Blazeby JM, Mendall MA, Hardwick RH, Linklater KM, Møller H, Davies EA (2012) Incidence and survival of oesophageal and gastric cancer in England between 1998 and 2007, a populationbased study. BMC Cancer 12: 11.
3. Feng Y-B, Lin D-C, Shi Z-Z, Wang X-C, Shen X-M, Zhang Y, Du X-L, Luo M-L, Xu X, Han Y-L, Cai Y, Zhang Z-Q, Zhan Q-M, Wang M-R (2009) Overexpression of PLK1 is associated with poor survival by inhibiting apoptosis via enhancement of survivin level in esophageal squamous cell carcinoma. Int J Cancer 124: 578-588.
4. Fu Z, Malureanu L, Huang J, Wang W, Li H, van Deursen JM, Tindal DJ, Chen J (2008) Plk1-dependent phosphorylation of FoxM1 regulates a transcriptional programme required for mitotic progression. Nat Cell Biol 10: 1076-1082.
5. Hampel H, Abraham NS, El-Serag HB (2005) Meta-Analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med 143: 199-211. (Pubitemid 41076753)
6. Hui MKC, Chan KW, Luk JM, Lee NP, Chung Y, Cheung LCM, Srivastava G, Tsao SW, Tang JC, Law S (2012) Cytoplasmic forkhead Box M1 (FoxM1) in esophageal squamous cell carcinoma significantly correlates with pathological disease stage. World J Surg 36: 90-97.
7. Keld R, Guo B, Downey P, Gulmann C, Ang YS, Sharrocks AD (2010) The ERK MAP kinase-PEA3/ETV4-MMP-1 axis is operative in oesophageal adenocarcinoma. Mol Cancer 9: 313.
8. Kim SM, Park Y-Y, Park ES, Cho JY, Izzo JG, Zhang D, Kim S-B, Lee JH, Bhutani MS, Swisher SG, Wu X, Coombes KR, Maru D, Wang KK, Buttar NS, Ajani JA, Lee J-S (2010) Prognostic biomarkers for esophageal adenocarcinoma identified by analysis of tumor transcriptome. PLoS ONE 5: e15074.
9. Koike T, Ohara S, Sekine H, Iijima K, Abe Y, Kato K, Toyota T, Shimosegawa T (2001) Helicobacter Pylori infection prevents erosive reflux oesophagitis by decreasing gastric acid secretion. Gut 49: 330-334. (Pubitemid 32802565)
10. Koo C-Y, Muir KW, Lam EW (2012) FOXM1: from cancer initiation to progression and treatment. Biochim Biophys Acta 1819: 28-37.
11. Lao-Sirieix P, Boussioutas A, Kadri SR, O'Donovan M, Debiram I, Das M, Harihar L, Fitzgerald RC (2009) Non-endoscopic screening biomarkers for Barrett's oesophagus: from microarray analysis to the clinic. Gut 58: 1451-1459.
12. Laoukili J, Kooistra MRH, Brás A, Kauw J, Kerkhoven RM, Morrison A, Clevers H, Medema RH (2005) FoxM1 is required for execution of the mitotic programme and chromosome stability. Nat Cell Biol 7: 126-136. (Pubitemid 40268127)
13. Laoukili J, Stahl M, Medema RH (2007) FoxM1: At the crossroads of ageing and cancer. Biochim Biophys Acta 1775: 92-102. (Pubitemid 44881197)
14. Lens SMA, Voest EE, Medema RH (2010) Shared and separate functions of polo-like kinases and aurora kinases in cancer. Nat Rev Cancer 10: 825-841.
15. Major ML, Lepe R, Costa RH (2004) Forkhead Box M1B transcriptional activity requires binding of Cdk-Cyclin complexes for phosphorylationdependent recruitment of p300/CBP coactivators. Mol Cell Biol 24: 2649-2661. (Pubitemid 38381258)
16. Peters CJ, Rees JRE, Hardwick RH, Hardwick JS, Vowler SL, Ong C-AJ, Zhang C, Save V, O'Donovan M, Rassl D, Alderson D, Caldas C, Fitzgerald RC (2010) A 4-gene signature predicts survival of patients with resected adenocarcinoma of the esophagus, junction, and gastric cardia. Gastroenterology 139: 1995-2004.
17. Raychaudhuri P, Park HJ (2011) FoxM1: A master regulator of tumor metastasis. Cancer Res 71: 4329-4333.
18. Saeed AI, Bhagabati NK, Braisted JC, Liang W, Sharov V, Howe EA, Li J, Thiagarajan M, White JA, Quackenbush J (2006) TM4 microarray software suite. Methods Enzymol 411: 134-193.
19. Solaymani-Dodaran M, Logan RFA, West J, Card T, Coupland C (2004) Risk of oesophageal cancer in Barrett's oesophagus and gastrooesophageal reflux. Gut 53: 1070-1074. (Pubitemid 38961957)
20. Strebhardt K, Ullrich A (2006) Targeting polo-like kinase 1 for cancer therapy. Nat Rev Cancer 6: 321-330.
21. Whitfield ML, Zheng L-X, Baldwin A, Ohta T, Hurt MM, Marzluff WF (2000) Stem-loop binding protein, the protein that binds the 30 end of histone mRNA, is cell cycle regulated by both translational and posttranslational mechanisms. Mol Cell Biol 20: 4188-4198. (Pubitemid 30346615)
22. Ye H, Kelly TF, Samadani U, Lim L, Rubio S, Overdier DG, Roebuck KA, Costa RH (1997) Hepatocyte nuclear factor 3/fork head homolog 11 is expressed in proliferating epithelial and mesenchymal cells of embryonic and adult tissues. Mol Cell Biol 17: 1626-1641. (Pubitemid 27097392)
23. Zhang N, Wei P, Gong A, Chiu WT, Lee HT, Colman H, Huang H, Xue J, Liu M, Wang Y, Sawaya R, Xie K, Yung WK, Medema RH, He X, Huang S (2011) FoxM1 promotes b-catenin nuclear localization and controls Wnt target-gene expression and glioma tumorigenesis. Cancer Cell 20: 427-442.
24. Zhao C, Gong L, Li W, Chen L (2010) Overexpression of Plk1 promotes malignant progress in human esophageal squamous cell carcinoma. J Cancer Res Clin Oncol 136: 9-16